Pharmaceuticals, Biotechnology and Life Sciences
Proceeds will enable advancement and acceleration of the Company’s transformative drug discovery programs derived from digital search of the fungal…
WALTHAM, Mass.–(BUSINESS WIRE)–TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR)-engineered T cell therapies in oncology,…
— Partnership combines ArsenalBio’s programmable cell therapy approach with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development…
— Partnership combines ArsenalBio’s programmable cell therapy approach with Bristol Myers Squibb’s expertise in cell therapy and oncology drug development…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
– Vutrisiran Met Primary and All Secondary Endpoints at 9 Months, with Statistically Significant Improvements in Progression of Neuropathy, Quality…
NEW YORK & TORONTO–(BUSINESS WIRE)–Cyclica announced the election of Sastry Chilukuri to its Board of Directors effective immediately. Chilukuri was…
Proceeds will enable advancement and acceleration of the Company’s transformative drug discovery programs derived from digital search of the fungal…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…
— First and only prescription therapy approved specifically for short-term treatment of the signs and symptoms of dry eye disease…